Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema
Clinical trial NCT02079688 · COMPLETED
Trial details
- NCT number
- NCT02079688
- Sponsor
- Sterna Biologicals GmbH & Co. KG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2016-11-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.